世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
液体ベースの無針注射器 - 世界市場シェアとランキング、全体売上高と需要予測 2024-2030Liquid-based Needle-Free Injector - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 今すぐお問い合わせ 無針注射は、皮下注射針の使用を実質的に無効にし、皮膚を通して薬物の送達を可能にする技術である。液体ベースの無針注射器は、注射剤に充填される薬剤が液体である場合に使用されます。こ... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー今すぐお問い合わせ無針注射は、皮下注射針の使用を実質的に無効にし、皮膚を通して薬物の送達を可能にする技術である。液体ベースの無針注射器は、注射剤に充填される薬剤が液体である場合に使用されます。この技術は、進化する製薬業界にとって非常に有益である。1本の注射針を複数回使用することによる針刺し損傷やその他の合併症の可能性を減らすことができるため、集団予防接種のプログラム作成に有用である。 1本の注射針を複数回使用することによる合併症がないこと、針刺し傷害を発症する可能性が低いこと、液体ベースの無針注射器開発のための技術の進歩が、世界の液体ベースの無針注射器市場の成長を牽引している。しかし、技術的な課題が市場の成長を抑制している。 液体ベースの無針注射器の世界市場は、2023年には百万米ドルの価値があると推定され、2024-2030年の予測期間中にCAGR %で2030年までに百万米ドルの再調整された規模になると予測されている。 液体ベースの無針注射器の北米市場は、2023年に百万ドルと評価され、2024年から2030年の予測期間中に％CAGRで、2030年までに百万ドルに達すると予測されています。 液体ベースのニードルフリー注射器のアジア太平洋市場は、2023年に100万ドルと評価され、2024年から2030年の予測期間中に％のCAGRで、2030年までに100万ドルに達するだろう。 液体ベース無針注射器のヨーロッパ市場は2023年に100万ドルと評価され、2024年から2030年の予測期間に年平均成長率%で、2030年までに100万ドルに達する見込みである。 液体無針注射器の世界の主要企業は、Antares Pharma、Bioject Medical Technologies、Medical International Technology、Endo International、National Medical Products、Valeritas、European Pharma Group、Crossject SAなどである。2023年には、世界の大手5社が売上高で約 %のシェアを占めている。 レポートの範囲 本レポートは、液体無針注射器の世界市場を包括的に紹介することを目的とし、総販売量、販売収益、価格、主要企業の市場シェアとランキングに焦点を当て、液体無針注射器の地域別・国別、タイプ別、用途別の分析も併せて掲載しています。 液体式無針注射器の市場規模、推計、予測は、2023年を基準年として、2019年から2030年までの期間の履歴データと予測データを売上数量（Kユニット）と売上収益（百万ドル）で提供します。定量分析および定性分析により、読者が事業/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、液体ベースの無針注射器に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 アンタレスファーマ バイオジェクト・メディカル・テクノロジーズ メディカル・インターナショナル・テクノロジー エンド・インターナショナル ナショナル・メディカル・プロダクツ バレリータス ヨーロピアンファーマグループ クロスジェクトSA タイプ別セグメント ジェット スプリング レーザー 振動 用途別セグメント 病院 クリニック 地域別 北米 米国 カナダ ヨーロッパ ドイツ フランス 英国 イタリア ロシア アジア太平洋 中国 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 各章の概要 第1章： レポートの対象範囲、世界の総市場規模（バルブ、数量、価格）を紹介。この章ではまた、市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：液体ベースの無針注射器メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併、買収情報などを詳細に分析します。 第3章：タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのを助ける。 第4章：用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。 第5章：地域レベルでの液体ベース無針注射器の販売、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展展望、市場空間、市場規模を紹介する。 第6章 液体ベース無針注射器の国別売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。 第7章：主要企業のプロファイルを提供し、製品の売上高、収益、価格、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Liquid-based Needle-Free Injector Product Introduction 1.2 Global Liquid-based Needle-Free Injector Market Size Forecast 1.2.1 Global Liquid-based Needle-Free Injector Sales Value (2019-2030) 1.2.2 Global Liquid-based Needle-Free Injector Sales Volume (2019-2030) 1.2.3 Global Liquid-based Needle-Free Injector Sales Price (2019-2030) 1.3 Liquid-based Needle-Free Injector Market Trends & Drivers 1.3.1 Liquid-based Needle-Free Injector Industry Trends 1.3.2 Liquid-based Needle-Free Injector Market Drivers & Opportunity 1.3.3 Liquid-based Needle-Free Injector Market Challenges 1.3.4 Liquid-based Needle-Free Injector Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Liquid-based Needle-Free Injector Players Revenue Ranking (2023) 2.2 Global Liquid-based Needle-Free Injector Revenue by Company (2019-2024) 2.3 Global Liquid-based Needle-Free Injector Players Sales Volume Ranking (2023) 2.4 Global Liquid-based Needle-Free Injector Sales Volume by Company Players (2019-2024) 2.5 Global Liquid-based Needle-Free Injector Average Price by Company (2019-2024) 2.6 Key Manufacturers Liquid-based Needle-Free Injector Manufacturing Base Distribution and Headquarters 2.7 Key Manufacturers Liquid-based Needle-Free Injector Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Liquid-based Needle-Free Injector 2.9 Liquid-based Needle-Free Injector Market Competitive Analysis 2.9.1 Liquid-based Needle-Free Injector Market Concentration Rate (2019-2024) 2.9.2 Global 5 and 10 Largest Manufacturers by Liquid-based Needle-Free Injector Revenue in 2023 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid-based Needle-Free Injector as of 2023) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Jet 3.1.2 Spring 3.1.3 Laser 3.1.4 Vibration 3.2 Global Liquid-based Needle-Free Injector Sales Value by Type 3.2.1 Global Liquid-based Needle-Free Injector Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Liquid-based Needle-Free Injector Sales Value, by Type (2019-2030) 3.2.3 Global Liquid-based Needle-Free Injector Sales Value, by Type (%) (2019-2030) 3.3 Global Liquid-based Needle-Free Injector Sales Volume by Type 3.3.1 Global Liquid-based Needle-Free Injector Sales Volume by Type (2019 VS 2023 VS 2030) 3.3.2 Global Liquid-based Needle-Free Injector Sales Volume, by Type (2019-2030) 3.3.3 Global Liquid-based Needle-Free Injector Sales Volume, by Type (%) (2019-2030) 3.4 Global Liquid-based Needle-Free Injector Average Price by Type (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Clinics 4.2 Global Liquid-based Needle-Free Injector Sales Value by Application 4.2.1 Global Liquid-based Needle-Free Injector Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Liquid-based Needle-Free Injector Sales Value, by Application (2019-2030) 4.2.3 Global Liquid-based Needle-Free Injector Sales Value, by Application (%) (2019-2030) 4.3 Global Liquid-based Needle-Free Injector Sales Volume by Application 4.3.1 Global Liquid-based Needle-Free Injector Sales Volume by Application (2019 VS 2023 VS 2030) 4.3.2 Global Liquid-based Needle-Free Injector Sales Volume, by Application (2019-2030) 4.3.3 Global Liquid-based Needle-Free Injector Sales Volume, by Application (%) (2019-2030) 4.4 Global Liquid-based Needle-Free Injector Average Price by Application (2019-2030) 5 Segmentation by Region 5.1 Global Liquid-based Needle-Free Injector Sales Value by Region 5.1.1 Global Liquid-based Needle-Free Injector Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Liquid-based Needle-Free Injector Sales Value by Region (2019-2024) 5.1.3 Global Liquid-based Needle-Free Injector Sales Value by Region (2025-2030) 5.1.4 Global Liquid-based Needle-Free Injector Sales Value by Region (%), (2019-2030) 5.2 Global Liquid-based Needle-Free Injector Sales Volume by Region 5.2.1 Global Liquid-based Needle-Free Injector Sales Volume by Region: 2019 VS 2023 VS 2030 5.2.2 Global Liquid-based Needle-Free Injector Sales Volume by Region (2019-2024) 5.2.3 Global Liquid-based Needle-Free Injector Sales Volume by Region (2025-2030) 5.2.4 Global Liquid-based Needle-Free Injector Sales Volume by Region (%), (2019-2030) 5.3 Global Liquid-based Needle-Free Injector Average Price by Region (2019-2030) 5.4 North America 5.4.1 North America Liquid-based Needle-Free Injector Sales Value, 2019-2030 5.4.2 North America Liquid-based Needle-Free Injector Sales Value by Country (%), 2023 VS 2030 5.5 Europe 5.5.1 Europe Liquid-based Needle-Free Injector Sales Value, 2019-2030 5.5.2 Europe Liquid-based Needle-Free Injector Sales Value by Country (%), 2023 VS 2030 5.6 Asia Pacific 5.6.1 Asia Pacific Liquid-based Needle-Free Injector Sales Value, 2019-2030 5.6.2 Asia Pacific Liquid-based Needle-Free Injector Sales Value by Country (%), 2023 VS 2030 5.7 South America 5.7.1 South America Liquid-based Needle-Free Injector Sales Value, 2019-2030 5.7.2 South America Liquid-based Needle-Free Injector Sales Value by Country (%), 2023 VS 2030 5.8 Middle East & Africa 5.8.1 Middle East & Africa Liquid-based Needle-Free Injector Sales Value, 2019-2030 5.8.2 Middle East & Africa Liquid-based Needle-Free Injector Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Liquid-based Needle-Free Injector Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Liquid-based Needle-Free Injector Sales Value 6.2.1 Key Countries/Regions Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.2.2 Key Countries/Regions Liquid-based Needle-Free Injector Sales Volume, 2019-2030 6.3 United States 6.3.1 United States Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.3.2 United States Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.4.2 Europe Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.5.2 China Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.5.3 China Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.6.2 Japan Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.7.2 South Korea Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.8.2 Southeast Asia Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.9.2 India Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.9.3 India Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Antares Pharma 7.1.1 Antares Pharma Company Information 7.1.2 Antares Pharma Introduction and Business Overview 7.1.3 Antares Pharma Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.1.4 Antares Pharma Liquid-based Needle-Free Injector Product Offerings 7.1.5 Antares Pharma Recent Development 7.2 Bioject Medical Technologies 7.2.1 Bioject Medical Technologies Company Information 7.2.2 Bioject Medical Technologies Introduction and Business Overview 7.2.3 Bioject Medical Technologies Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.2.4 Bioject Medical Technologies Liquid-based Needle-Free Injector Product Offerings 7.2.5 Bioject Medical Technologies Recent Development 7.3 Medical International Technology 7.3.1 Medical International Technology Company Information 7.3.2 Medical International Technology Introduction and Business Overview 7.3.3 Medical International Technology Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.3.4 Medical International Technology Liquid-based Needle-Free Injector Product Offerings 7.3.5 Medical International Technology Recent Development 7.4 Endo International 7.4.1 Endo International Company Information 7.4.2 Endo International Introduction and Business Overview 7.4.3 Endo International Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.4.4 Endo International Liquid-based Needle-Free Injector Product Offerings 7.4.5 Endo International Recent Development 7.5 National Medical Products 7.5.1 National Medical Products Company Information 7.5.2 National Medical Products Introduction and Business Overview 7.5.3 National Medical Products Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.5.4 National Medical Products Liquid-based Needle-Free Injector Product Offerings 7.5.5 National Medical Products Recent Development 7.6 Valeritas 7.6.1 Valeritas Company Information 7.6.2 Valeritas Introduction and Business Overview 7.6.3 Valeritas Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.6.4 Valeritas Liquid-based Needle-Free Injector Product Offerings 7.6.5 Valeritas Recent Development 7.7 European Pharma Group 7.7.1 European Pharma Group Company Information 7.7.2 European Pharma Group Introduction and Business Overview 7.7.3 European Pharma Group Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.7.4 European Pharma Group Liquid-based Needle-Free Injector Product Offerings 7.7.5 European Pharma Group Recent Development 7.8 Crossject SA 7.8.1 Crossject SA Company Information 7.8.2 Crossject SA Introduction and Business Overview 7.8.3 Crossject SA Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.8.4 Crossject SA Liquid-based Needle-Free Injector Product Offerings 7.8.5 Crossject SA Recent Development 8 Industry Chain Analysis 8.1 Liquid-based Needle-Free Injector Industrial Chain 8.2 Liquid-based Needle-Free Injector Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Liquid-based Needle-Free Injector Sales Model 8.5.2 Sales Channel 8.5.3 Liquid-based Needle-Free Injector Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryEnquiry Now Table of Contents1 Market Overview1.1 Liquid-based Needle-Free Injector Product Introduction 1.2 Global Liquid-based Needle-Free Injector Market Size Forecast 1.2.1 Global Liquid-based Needle-Free Injector Sales Value (2019-2030) 1.2.2 Global Liquid-based Needle-Free Injector Sales Volume (2019-2030) 1.2.3 Global Liquid-based Needle-Free Injector Sales Price (2019-2030) 1.3 Liquid-based Needle-Free Injector Market Trends & Drivers 1.3.1 Liquid-based Needle-Free Injector Industry Trends 1.3.2 Liquid-based Needle-Free Injector Market Drivers & Opportunity 1.3.3 Liquid-based Needle-Free Injector Market Challenges 1.3.4 Liquid-based Needle-Free Injector Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Liquid-based Needle-Free Injector Players Revenue Ranking (2023) 2.2 Global Liquid-based Needle-Free Injector Revenue by Company (2019-2024) 2.3 Global Liquid-based Needle-Free Injector Players Sales Volume Ranking (2023) 2.4 Global Liquid-based Needle-Free Injector Sales Volume by Company Players (2019-2024) 2.5 Global Liquid-based Needle-Free Injector Average Price by Company (2019-2024) 2.6 Key Manufacturers Liquid-based Needle-Free Injector Manufacturing Base Distribution and Headquarters 2.7 Key Manufacturers Liquid-based Needle-Free Injector Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Liquid-based Needle-Free Injector 2.9 Liquid-based Needle-Free Injector Market Competitive Analysis 2.9.1 Liquid-based Needle-Free Injector Market Concentration Rate (2019-2024) 2.9.2 Global 5 and 10 Largest Manufacturers by Liquid-based Needle-Free Injector Revenue in 2023 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid-based Needle-Free Injector as of 2023) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Jet 3.1.2 Spring 3.1.3 Laser 3.1.4 Vibration 3.2 Global Liquid-based Needle-Free Injector Sales Value by Type 3.2.1 Global Liquid-based Needle-Free Injector Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Liquid-based Needle-Free Injector Sales Value, by Type (2019-2030) 3.2.3 Global Liquid-based Needle-Free Injector Sales Value, by Type (%) (2019-2030) 3.3 Global Liquid-based Needle-Free Injector Sales Volume by Type 3.3.1 Global Liquid-based Needle-Free Injector Sales Volume by Type (2019 VS 2023 VS 2030) 3.3.2 Global Liquid-based Needle-Free Injector Sales Volume, by Type (2019-2030) 3.3.3 Global Liquid-based Needle-Free Injector Sales Volume, by Type (%) (2019-2030) 3.4 Global Liquid-based Needle-Free Injector Average Price by Type (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Clinics 4.2 Global Liquid-based Needle-Free Injector Sales Value by Application 4.2.1 Global Liquid-based Needle-Free Injector Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Liquid-based Needle-Free Injector Sales Value, by Application (2019-2030) 4.2.3 Global Liquid-based Needle-Free Injector Sales Value, by Application (%) (2019-2030) 4.3 Global Liquid-based Needle-Free Injector Sales Volume by Application 4.3.1 Global Liquid-based Needle-Free Injector Sales Volume by Application (2019 VS 2023 VS 2030) 4.3.2 Global Liquid-based Needle-Free Injector Sales Volume, by Application (2019-2030) 4.3.3 Global Liquid-based Needle-Free Injector Sales Volume, by Application (%) (2019-2030) 4.4 Global Liquid-based Needle-Free Injector Average Price by Application (2019-2030) 5 Segmentation by Region 5.1 Global Liquid-based Needle-Free Injector Sales Value by Region 5.1.1 Global Liquid-based Needle-Free Injector Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Liquid-based Needle-Free Injector Sales Value by Region (2019-2024) 5.1.3 Global Liquid-based Needle-Free Injector Sales Value by Region (2025-2030) 5.1.4 Global Liquid-based Needle-Free Injector Sales Value by Region (%), (2019-2030) 5.2 Global Liquid-based Needle-Free Injector Sales Volume by Region 5.2.1 Global Liquid-based Needle-Free Injector Sales Volume by Region: 2019 VS 2023 VS 2030 5.2.2 Global Liquid-based Needle-Free Injector Sales Volume by Region (2019-2024) 5.2.3 Global Liquid-based Needle-Free Injector Sales Volume by Region (2025-2030) 5.2.4 Global Liquid-based Needle-Free Injector Sales Volume by Region (%), (2019-2030) 5.3 Global Liquid-based Needle-Free Injector Average Price by Region (2019-2030) 5.4 North America 5.4.1 North America Liquid-based Needle-Free Injector Sales Value, 2019-2030 5.4.2 North America Liquid-based Needle-Free Injector Sales Value by Country (%), 2023 VS 2030 5.5 Europe 5.5.1 Europe Liquid-based Needle-Free Injector Sales Value, 2019-2030 5.5.2 Europe Liquid-based Needle-Free Injector Sales Value by Country (%), 2023 VS 2030 5.6 Asia Pacific 5.6.1 Asia Pacific Liquid-based Needle-Free Injector Sales Value, 2019-2030 5.6.2 Asia Pacific Liquid-based Needle-Free Injector Sales Value by Country (%), 2023 VS 2030 5.7 South America 5.7.1 South America Liquid-based Needle-Free Injector Sales Value, 2019-2030 5.7.2 South America Liquid-based Needle-Free Injector Sales Value by Country (%), 2023 VS 2030 5.8 Middle East & Africa 5.8.1 Middle East & Africa Liquid-based Needle-Free Injector Sales Value, 2019-2030 5.8.2 Middle East & Africa Liquid-based Needle-Free Injector Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Liquid-based Needle-Free Injector Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Liquid-based Needle-Free Injector Sales Value 6.2.1 Key Countries/Regions Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.2.2 Key Countries/Regions Liquid-based Needle-Free Injector Sales Volume, 2019-2030 6.3 United States 6.3.1 United States Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.3.2 United States Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.4.2 Europe Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.5.2 China Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.5.3 China Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.6.2 Japan Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.7.2 South Korea Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.8.2 Southeast Asia Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Liquid-based Needle-Free Injector Sales Value, 2019-2030 6.9.2 India Liquid-based Needle-Free Injector Sales Value by Type (%), 2023 VS 2030 6.9.3 India Liquid-based Needle-Free Injector Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Antares Pharma 7.1.1 Antares Pharma Company Information 7.1.2 Antares Pharma Introduction and Business Overview 7.1.3 Antares Pharma Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.1.4 Antares Pharma Liquid-based Needle-Free Injector Product Offerings 7.1.5 Antares Pharma Recent Development 7.2 Bioject Medical Technologies 7.2.1 Bioject Medical Technologies Company Information 7.2.2 Bioject Medical Technologies Introduction and Business Overview 7.2.3 Bioject Medical Technologies Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.2.4 Bioject Medical Technologies Liquid-based Needle-Free Injector Product Offerings 7.2.5 Bioject Medical Technologies Recent Development 7.3 Medical International Technology 7.3.1 Medical International Technology Company Information 7.3.2 Medical International Technology Introduction and Business Overview 7.3.3 Medical International Technology Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.3.4 Medical International Technology Liquid-based Needle-Free Injector Product Offerings 7.3.5 Medical International Technology Recent Development 7.4 Endo International 7.4.1 Endo International Company Information 7.4.2 Endo International Introduction and Business Overview 7.4.3 Endo International Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.4.4 Endo International Liquid-based Needle-Free Injector Product Offerings 7.4.5 Endo International Recent Development 7.5 National Medical Products 7.5.1 National Medical Products Company Information 7.5.2 National Medical Products Introduction and Business Overview 7.5.3 National Medical Products Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.5.4 National Medical Products Liquid-based Needle-Free Injector Product Offerings 7.5.5 National Medical Products Recent Development 7.6 Valeritas 7.6.1 Valeritas Company Information 7.6.2 Valeritas Introduction and Business Overview 7.6.3 Valeritas Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.6.4 Valeritas Liquid-based Needle-Free Injector Product Offerings 7.6.5 Valeritas Recent Development 7.7 European Pharma Group 7.7.1 European Pharma Group Company Information 7.7.2 European Pharma Group Introduction and Business Overview 7.7.3 European Pharma Group Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.7.4 European Pharma Group Liquid-based Needle-Free Injector Product Offerings 7.7.5 European Pharma Group Recent Development 7.8 Crossject SA 7.8.1 Crossject SA Company Information 7.8.2 Crossject SA Introduction and Business Overview 7.8.3 Crossject SA Liquid-based Needle-Free Injector Sales, Revenue and Gross Margin (2019-2024) 7.8.4 Crossject SA Liquid-based Needle-Free Injector Product Offerings 7.8.5 Crossject SA Recent Development 8 Industry Chain Analysis 8.1 Liquid-based Needle-Free Injector Industrial Chain 8.2 Liquid-based Needle-Free Injector Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Liquid-based Needle-Free Injector Sales Model 8.5.2 Sales Channel 8.5.3 Liquid-based Needle-Free Injector Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社の医療機器・消耗品分野での最新刊レポート
本レポートと同じKEY WORD（）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/20 10:26 155.91 円 165.77 円 200.60 円 |